YMTX Annual CFF
-$1.03 M
-$56.57 M-101.86%
31 December 2021
Summary:
As of February 5, 2025, YMTX annual cash flow from financing activities is -$1.03 million, with the most recent change of -$56.57 million (-101.86%) on December 31, 2021. During the last 3 years, it has fallen by -$4.06 million (-134.15%).YMTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMTX Quarterly CFF
-$578.00 K
+$10.00 K+1.70%
30 September 2022
Summary:
As of February 5, 2025, YMTX quarterly cash flow from financing activities is -$578.00 thousand, with the most recent change of +$10.00 thousand (+1.70%) on September 30, 2022. Over the past year, it has increased by +$322.00 thousand (+35.78%).YMTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMTX TTM CFF
-$13.67 M
+$322.00 K+2.30%
30 September 2022
Summary:
As of February 5, 2025, YMTX TTM cash flow from financing activities is -$13.67 million, with the most recent change of +$322.00 thousand (+2.30%) on September 30, 2022. Over the past year, it has dropped by -$47.44 million (-140.47%).YMTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMTX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -101.9% | +35.8% | -140.5% |
| 3 y3 years | -134.2% | -556.8% | -10000.0% |
| 5 y5 years | -134.2% | -556.8% | -10000.0% |
YMTX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -101.9% | -101.7% | -124.6% |
Yumanity Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$578.00 K(-1.7%) | -$13.67 M(-2.3%) |
| June 2022 | - | -$588.00 K(-94.8%) | -$13.99 M(+15.6%) |
| Mar 2022 | - | -$11.21 M(+767.6%) | -$12.10 M(+1071.4%) |
| Dec 2021 | -$1.03 M | -$1.29 M(+43.6%) | -$1.03 M(-103.1%) |
| Sept 2021 | - | -$900.00 K(-169.2%) | $33.77 M(-1.8%) |
| June 2021 | - | $1.30 M(-1016.2%) | $34.40 M(-38.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$142.00 K(-100.4%) | $55.48 M(-0.1%) |
| Dec 2020 | $55.54 M(+1735.9%) | $33.51 M(<-9900.0%) | $55.54 M(+152.2%) |
| Sept 2020 | - | -$273.00 K(-101.2%) | $22.02 M(-1.2%) |
| June 2020 | - | $22.38 M(<-9900.0%) | $22.30 M(<-9900.0%) |
| Mar 2020 | - | -$88.00 K | -$88.00 K |
| Dec 2019 | $3.02 M | - | - |
FAQ
- What is Yumanity Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Yumanity Therapeutics?
- What is Yumanity Therapeutics annual CFF year-on-year change?
- What is Yumanity Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Yumanity Therapeutics?
- What is Yumanity Therapeutics quarterly CFF year-on-year change?
- What is Yumanity Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Yumanity Therapeutics?
- What is Yumanity Therapeutics TTM CFF year-on-year change?
What is Yumanity Therapeutics annual cash flow from financing activities?
The current annual CFF of YMTX is -$1.03 M
What is the all time high annual CFF for Yumanity Therapeutics?
Yumanity Therapeutics all-time high annual cash flow from financing activities is $55.54 M
What is Yumanity Therapeutics annual CFF year-on-year change?
Over the past year, YMTX annual cash flow from financing activities has changed by -$56.57 M (-101.86%)
What is Yumanity Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of YMTX is -$578.00 K
What is the all time high quarterly CFF for Yumanity Therapeutics?
Yumanity Therapeutics all-time high quarterly cash flow from financing activities is $33.51 M
What is Yumanity Therapeutics quarterly CFF year-on-year change?
Over the past year, YMTX quarterly cash flow from financing activities has changed by +$322.00 K (+35.78%)
What is Yumanity Therapeutics TTM cash flow from financing activities?
The current TTM CFF of YMTX is -$13.67 M
What is the all time high TTM CFF for Yumanity Therapeutics?
Yumanity Therapeutics all-time high TTM cash flow from financing activities is $55.54 M
What is Yumanity Therapeutics TTM CFF year-on-year change?
Over the past year, YMTX TTM cash flow from financing activities has changed by -$47.44 M (-140.47%)